zofran birth defects

  • Date: Apr 28, 2015
  • Category: Family

Plaintiff In Texas Claims Zofran Caused “Numerous Birth Defects”

On April 17, 2015, a mother from Texarkana, Texas filed suit against GlaxoSmithKline, manufacturer of the anti-nausea drug Zofran. Plaintiff claims that Zofran, often prescribed “off-label” to treat morning sickness, caused her unborn child to develop multiple congenital defects. Continue reading →

  • Date: Mar 17, 2015
  • Category: Legal

Monheit Law Releases A 12 Point Guide To Zofran Birth Defect Lawsuits

In order to better inform the public, a national coalition of distinguished plaintiffs’ attorneys has released a comprehensive guide on litigation surrounding GlaxoSmithKline’s popular anti-nausea drug Zofran. Recent studies have begun to establish a link between Zofran’s active ingredient, Ondansetron, and severe birth defects including cleft palate and congenital heart defects. Now, recently-filed lawsuits (filed under case numbers 1:15-cv-10429 and 2:15-cv-00709PD) claim that GlaxoSmithKline was aware of Zofran’s risks, but unlawfully marketed the drug to obstetricians and gynecologists as a safe treatment for morning sickness. Continue reading →

National Alliance of Attorneys Filing Zofran Birth Defect Lawsuits

A national alliance of plaintiffs’ attorneys have begun filing Zofran birth defect lawsuits. Several independent studies have linked Zofran to a potential increased risk of child birth defects such as cleft palate, and congenital heart defects. Continue reading →